Bearish flow noted in Novo Nordisk (NVO) with 7,917 puts trading, or 1.2x expected. Most active are 3/14 weekly 76 puts and Sep-25 110 puts, ...

Novo Nordisk (NVO) stock rebounds after Kepler Cheuvreux upgrades to Buy following a 42% stock drop over the past year. Read ...

Shares of Novo Nordisk (NYSE: NVO) are tumbling on Monday. The company's stock lost 8.9% as of 10:10 a.m. ET and was down as much as 9.2% earlier in the day. The drop comes as the S&P 500 ...

Novo Nordisk released the results from its late-stage trial of CagriSema on Monday. It showed that patients on the highest dose of the drug lost 15.7% of their weight.

Shares of Novo Nordisk fell sharply on Monday, after the firm published results from the latest clinical trial of its ...

Novo Nordisk (NYSE: NVO) shareholders know all ... Unfortunately, shares of the company behind Ozempic have been trading about 39% below last year's peak. Now that it's been beaten down, ...

The stock is currently trading above its 50-day moving average but below its 200-day moving average. Several factors in the past three months caused Novo Nordisk's stock to dip. In December 2024 ...

Novo Nordisk said on Wednesday it would begin selling ... US-listed shares of Novo were up 4.2% to $91.16 in morning trading. Compounding pharmacies that have been selling hundreds of ...

Novo Nordisk shares fell after the pharmaceutical giant released fresh trial results for its CagriSema developmental weight-loss drug. The Danish company said CagriSema helped obese or overweight ...